Deep Track Capital’s Century Therapeutics IPSC Stock Holding History

Deep Track Capital’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.2M	Sell	9,462,645 -25,100	-0.3%	-$57.3K	0.34%	52
2026 Q1	$21.4M	Buy	+9,487,745	New	+$19.9M	0.35%	52
2023 Q4	–	Sell	-543,008	Closed	-$1.09M	–	69
2023 Q3	$1.09M	Sell	543,008 -479,884	-47%	-$1.28M	0.04%	63
2023 Q2	$3.23M	Hold	1,022,892	–	–	0.15%	50
2023 Q1	$3.55M	Buy	1,022,892 +327,047	+47%	+$1.44M	0.15%	55
2022 Q4	$3.57M	Sell	695,845 -228,796	-25%	-$2.16M	0.15%	53
2022 Q3	$9.14M	Hold	924,641	–	–	0.42%	53
2022 Q2	$7.77M	Sell	924,641 -1,828	-0.2%	-$17.9K	0.51%	40
2022 Q1	$11.7M	Buy	926,469 +676,469	+271%	+$8.96M	0.75%	35
2021 Q4	$3.96M	Buy	+250,000	New	+$4.7M	0.28%	51

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Deep Track Capital's IPSC Position: Q2 2026 in Review

Deep Track Capital reduced its Century Therapeutics (IPSC) stake by 0.26% in Q2 2026, selling an estimated $57.3K and leaving 9,462,645 shares worth $23.2M. The position accounts for 0.34% of the portfolio, ranked #52.

Deep Track Capital first reported a position in IPSC in Q4 2021 and has held it in 10 quarters since. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

Deep Track Capital held 9,462,645 shares of Century Therapeutics worth $23.2M as of Q2 2026.
Deep Track Capital sold 25,100 Century Therapeutics shares in Q2 2026, an estimated $57.3K.
Century Therapeutics made up 0.34% of Deep Track Capital's portfolio in Q2 2026, its #52 holding.
Deep Track Capital first reported a position in Century Therapeutics in Q4 2021 and has held it in 10 quarters since.
99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.